Lantern Pharma's Seed Round

Lantern Pharma raised a round of funding on August 25, 2014. Investors include Health Wildcatters.

Lantern Pharma is advancing precision cancer medicine by combining clinical stage chemotherapeutics with personalized genetic testing to de-risk clinical development.…

Articles about Lantern Pharma's Seed Round: